Primary cardiac angiosarcoma is extremely aggressive; however, it is often misdiagnosed because of its rarity. For locally advanced tumors, doxorubicin-based chemotherapy regimens are the standard of treatment, even if the gain in term of progression-free survival is limited and is no longer than 5 months.
Minichillo, S., Pantaleo, M.A., Nannini, M., Coccolo, F., Gatto, L., Biasco, G., et al. (2015). Efficacy of weekly docetaxel in locally advanced cardiac angiosarcoma. BMC RESEARCH NOTES, 8(1), 1-4 [10.1186/s13104-015-1296-4].
Efficacy of weekly docetaxel in locally advanced cardiac angiosarcoma
MINICHILLO, SANTINO;PANTALEO, MARIA ABBONDANZA;NANNINI, MARGHERITA;GATTO, LIDIA;BIASCO, GUIDO;BRANDI, GIOVANNI
2015
Abstract
Primary cardiac angiosarcoma is extremely aggressive; however, it is often misdiagnosed because of its rarity. For locally advanced tumors, doxorubicin-based chemotherapy regimens are the standard of treatment, even if the gain in term of progression-free survival is limited and is no longer than 5 months.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
s13104-015-1296-4.pdf
accesso aperto
Tipo:
Versione (PDF) editoriale
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione
935.45 kB
Formato
Adobe PDF
|
935.45 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
